Albertsons Companies Inc. (ACI)
NYSE: ACI
· Real-Time Price · USD
22.11
0.28 (1.28%)
At close: May 23, 2025, 3:59 PM
22.15
0.18%
After-hours: May 23, 2025, 05:49 PM EDT
Albertsons Companies Revenue Breakdown
| Period Ending | Feb 22, 2025 | Feb 24, 2024 | Feb 25, 2023 | Feb 26, 2022 | Feb 27, 2021 | Feb 29, 2020 | Feb 23, 2019 | Feb 24, 2018 |
|---|---|---|---|---|---|---|---|---|
| Fresh Revenue | 25.51B | 25.44B | 25.59B | 24.64B | 2.24B | 3.43B | 3.46B | 3.1B |
| Fresh Revenue Growth | +0.25% | -0.56% | +3.85% | +1001.58% | -34.80% | -0.74% | +11.32% | n/a |
| Fuel Revenue | 3.98B | 4.4B | 4.86B | 3.75B | 32.1B | 27.17B | 26.37B | 26.52B |
| Fuel Revenue Growth | -9.46% | -9.49% | +29.62% | -88.33% | +18.17% | +3.01% | -0.57% | n/a |
| Non-Perishables Revenue | 40.1B | 39.98B | 39.14B | 36.49B | 968.1M | 940.8M | 799.3M | 711.7M |
| Non-Perishables Revenue Growth | +0.31% | +2.13% | +7.28% | +3668.90% | +2.90% | +17.70% | +12.31% | n/a |
| Other Products and Services Revenue | 1.2B | 1.18B | 1.29B | 1.19B | 5.2B | 5.24B | 4.99B | 5B |
| Other Products and Services Revenue Growth | +1.86% | -8.80% | +8.58% | -77.04% | -0.78% | +5.02% | -0.32% | n/a |
| Pharmacy Revenue | 9.6B | 8.24B | 6.77B | 5.82B | n/a | n/a | n/a | n/a |
| Pharmacy Revenue Growth | +16.47% | +21.73% | +16.25% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Feb 22, 2025 | Nov 30, 2024 | Sep 7, 2024 | Jun 15, 2024 | Feb 24, 2024 | Dec 2, 2023 | Sep 9, 2023 | Jun 17, 2023 | Feb 25, 2023 | Dec 3, 2022 | Sep 10, 2022 | Jun 18, 2022 | Feb 26, 2022 | Dec 4, 2021 | Sep 11, 2021 | Jun 19, 2021 | Feb 27, 2021 | Dec 5, 2020 | Sep 12, 2020 | Jun 20, 2020 | Feb 29, 2020 | Nov 30, 2019 | Sep 7, 2019 | Jun 15, 2019 | Feb 23, 2019 | Dec 1, 2018 | Sep 8, 2018 | Jun 16, 2018 | Feb 24, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.84B | 4.72B | 4.79B | 5.68B | 4.71B | 4.16B | 4.19B | 5.49B | 4.71B | 4.53B | 4.1B | 5.86B | 4.32B | 4.24B | 4.23B | 5.5B | 4.73B | 4.31B | 4.03B | 5.77B | 4.09B | 3.81B | 3.79B | 4.92B | 3.77B | 3.68B | 3.68B | 4.98B | 3.71B | 3.73B | 3.81B | 4.97B | 3.75B | 3.67B | 3.66B | 4.92B | 3.72B | 3.53B | 3.59B | 4.82B | 3.15B |
| Selling, General, and Administrative Revenue Growth | +2.52% | -1.41% | -15.69% | +20.39% | +13.28% | -0.61% | -23.68% | +16.44% | +3.97% | +10.64% | -30.15% | +35.69% | +1.83% | +0.30% | -23.12% | +16.45% | +9.68% | +6.89% | -30.13% | +40.94% | +7.52% | +0.33% | -22.84% | +30.44% | +2.51% | -0.09% | -26.04% | +34.00% | -0.30% | -2.14% | -23.36% | +32.56% | +2.23% | +0.03% | -25.54% | +32.27% | +5.32% | -1.46% | -25.64% | +53.15% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |